700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02050

Synthetic patientMETA-24 · Day 102 · 65–74 · F · baseline S04Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
19%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S04
  2. Day 23 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 23.

Primary contributors, last 14 days
  • Inflammatory activity+11
  • Treatment adherence+5
  • GI instability+4
  • Nutritional resilience-4
  • Toxicity-4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    84 min
    stable · -0.7 vs previous 14 d
    Sleep duration
    Wearable
    6.8 h
    stable · -0.0 vs previous 14 d
    Energy level
    Daily log
    5.2/10
    stable · -0.3 vs previous 14 d
    Steps
    Wearable
    8,249
    stable · +271 vs previous 14 d
    GI burden
    Companion
    21.2/100
    improving · -9.5 vs previous 14 d
    Adherence
    Companion
    95.8 %
    stable · +0.6 vs previous 14 d
    Sleep quality
    Wearable
    43.7/100
    improving · +2.6 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    120 mg/dL
    stable · -3.6 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 70 from the failing basin, 19 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +9.3
    • Protein
      supporter · GI -6.4 next day
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • Poor metabolizer
      hidden · steering -12.7
    • Caffeine
      perturbation · steering -9.7
    • Ultra-processed food
      perturbation · steering -7.5
    • Caffeine
      detractor · GI +5.1 next day
    • Ultra-processed food
      detractor · GI +4.7 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -6.4supporter · 95%
    • Caffeine
      +5.1detractor · 95%
    • Ultra-processed food
      +4.7detractor · 95%
    • Dietary fat load
      +3.9detractor · 94%
    • Insoluble fibre
      -1.6no signal · 26%
    • Simple carbohydrates
      -1.4no signal · 26%
    • Alcohol
      -0.4no signal · 15%
    • Histamine load
      -0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production ↓60
      • MicrobiomeButyrate capacity 36/100
      • MicrobiomeF. prausnitzii depleted
    • Inflammatory signalling ↑45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Drug metabolism and exposure ↑40
      • DNACYP2D6 poor metabolizer → higher exposure
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    Microbiome
    Shannon diversity 3 · butyrate capacity 36/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    46 ms
    Sleep
    7.2 h
    Steps
    9,714
    Resting HR
    55 bpm
    Daily log: GI score 21, nutritional resilience 65, adherence 96.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0203134%S12AD-05improved47
    P-0209333%S05AD-05no change40
    P-0228533%S14AD-05no change39
    P-0248338%S06BR-03no change64
    P-0228035%S07BR-03no change50
    P-0208734%S01BR-03no change40
    P-0226734%S09BR-03no change45
    P-0252232%S01BR-03no change40
    P-0235435%S01CR-01improved78
    P-0212641%S16DT-01improved59
    P-0223541%S14DT-01improved50
    P-0221840%S01DT-01improved61